Jefferies Group’s Immunomedics Inc IMMU Stock Holding History

Jefferies Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-55,000	Closed	-$1.95K	–	1658
2020 Q2	$1.95K	Buy	+55,000	New	+$1.61M	0.02%	567
2020 Q1	–	Sell	-15,000	Closed	-$317K	–	2893
2019 Q4	$317K	Hold	15,000	–	–	﹤0.01%	2043
2019 Q3	$199K	Sell	15,000 -35,000	-70%	-$514K	﹤0.01%	2367
2019 Q2	$694K	Buy	50,000 +25,000	+100%	+$376K	0.01%	1493
2019 Q1	$480K	Buy	+25,000	New	+$403K	﹤0.01%	1608
2018 Q3	–	Sell	-60,000	Closed	-$1.42M	–	2877
2018 Q2	$1.42M	Buy	+60,000	New	+$1.21M	0.01%	1071
2018 Q1	–	Sell	-142,600	Closed	-$2.3M	–	2906
2017 Q4	$2.3M	Sell	142,600 -25,000	-15%	-$295K	0.01%	922
2017 Q3	$2.34M	Sell	167,600 -100,000	-37%	-$997K	0.02%	867
2017 Q2	$2.36M	Buy	267,600 +161,400	+152%	+$1.13M	0.02%	871
2017 Q1	$687K	Buy	+106,200	New	+$538K	0.01%	1456
2016 Q3	–	Sell	-38,300	Closed	-$89K	–	2553
2016 Q2	$89K	Buy	+38,300	New	+$128K	﹤0.01%	1950

Jefferies Group's IMMU Position: Q4 2020 in Review

Jefferies Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 160,160 shares — an estimated $13.6M sold.

Jefferies Group first reported a position in IMMU in Q2 2016 and held it in 5 quarters. The position peaked at $13.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Jefferies Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Jefferies Group sold 160,160 Immunomedics Inc shares in Q4 2020, an estimated $13.6M.
Jefferies Group first reported a position in Immunomedics Inc in Q2 2016 and held it in 5 quarters.
Jefferies Group's Immunomedics Inc position peaked at $13.6M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Jefferies Group's 13F filing for Q4 2020, filed 16 Feb 2021.